Shenzhen CMEF | Wondfo's Multiple-Scenario Solutions Made an Impression
October 20,2021 (Edit) Wondfo
From 13th to 16th Oct., the 85th China International Medical Devices (Autumn) Exposition (2021CMEF) was held in Shenzhen, China.


Wondfo presented a full range of products and multi-scenario solutions at booth 14E16. Besides, we also held three roadshows on the spot about solutions for diagnosing coagulation diseases, cardiovascular diseases and sepsis.


With Products from All Platforms, Our Multiple-Scenario Solutions Made an Impression

Wondfo exhibited a full range of products in this CMEF, exhibiting major solutions for diagnosing emergency and severe diseases, COVID-19, infectious diseases, as well as molecular diagnostic products, DOA tests and family health management. Wondfo's multi-scenario solutions can provide optimum solutions for medical institutions, public health institutions, law enforcers and family health managers and improving efficiency of medical institutions in diagnosis.
 
Regarding diagnosis of emergency and severe diseases, Wondfo’s various packages of coagulation test items can be flexibly applied in laboratories and clinical departments, delivering accurate test results. In this way, we can timely detect coagulopathy of patients, accurately spot those at high risk of thrombosis and prevent venous thrombosis.


Wondfo’s COVID-19 solution can provide triple tests of “nucleic PCR + antigen + antibody”, including 2019-nCoV antibody test kits (colloidal gold), 2019-nCoV antigen test kits (colloidal gold) and many other kinds. The triple tests can be used in different stages of human infection with COVID-19, and thus can be applied in various scenarios of rapid test of COVID-19 on site.


Wondfo has an infectious disease solution with rapid test kits of colloidal gold platform. Multiple testing items are included covering respiratory infections, blood infections, tropical infections, and digestive infections. With Wondfo’s decades of R&D of rapid tests for infectious diseases, related products have been distributed to more than 140 countries and regions around the world.


Regarding Wondfo’s molecular diagnostic solution, we exhibited our latest molecular analyzer—fully automated rapid nucleic acid amplification analyzer. It includes a control module and a detection module, and matching disposable reagent cartridges are provided. The whole process of nucleic acid extraction, amplification and analysis can be automatically finished after adding samples, and results can be released within 1 hour and reports can be printed with embedded printer.
 
Different from conventional molecular laboratories with strict requirements on laboratory conditions, equipment and professionalism of practitioners, Wondfo's molecular diagnostic solution realizes the concept of “Sample In, Result Out”. One analyzer can be a comprehensive molecular diagnostic lab, allowing comprehensive tests for respiratory, digestive and reproductive infections. Wondfo molecular automated analyzer can be used in disease control centers, outpatient clinics, emergency rooms, customs, mobile hospitals, etc.


Wondfo's solution of DOA test allows comprehensive tests of various samples such as blood, urine, saliva, hair, and feces, and can be applied in both preliminary screening and confirmation.


Wondfo’s home test solution includes home tests for pregnancy and common flus. Colloidal gold home tests provide rapid and convenient tests for people to care for health of families.

 
3 Impressive Roadshows, Introducing Solutions for 3 Scenarios

On 13th October, the unveiling day, Wondfo held two roadshows, respectively introducing coagulation solution and cardiovascular disease detection solution to visitors.
 
Wondfo’s coagulation solution can deliver 5-item coagulation analysis, 6-item thrombosis screening, and thrombus elastography. The comprehensive covering of key coagulation indicators allows wide application in laboratories and clinical departments. This solution can monitor the whole stages of diseases, and thus we can timely detect coagulopathy of patients, accurately spot those at high risk of thrombosis and prevent venous thrombosis.


Wondfo’s solution for detecting cardiovascular diseases can monitor the entire progress of cardiovascular diseases. This solution is outstanding for its dual platforms of immunofluorescence and chemiluminescence together with the dual indictors of BNP/NT-proBNP and cardiac troponin. Analyzers of this solution has been widely applied in outpatient clinics, emergency rooms, cardiology departments, respiratory departments, ICU, etc.


On the morning of October 14, Wondfo held a roadshow for sepsis diagnosing solution. Sepsis is a severe, life-threatening organ dysfunction due to response imbalance of immune system caused by infection. It particularly endangers lives and health of people with weak physique such as pregnant women, infants and the elderly. However, it can be treated through early diagnosis together with timely and appropriate clinical reactions.


With the double platforms of immunofluorescence assay and chemiluminescence assay, Wondfo’s sepsis diagnosing solution can realize combinations of four key inflammatory indicators—IL-6, CRP, PCT, SAA—playing an unreplaceable role in rapid detection in early phase, identification of bacterial / viral infections and guidance on antibiotics usage.


Wondfo is driven by innovation and oriented by application scenarios. We keep improving us to provide our customers with better and more innovative products so as to meet their practical needs. Racing for life, we look forward to seeing you in next exhibition!